Tag - covid-19-vaccines

 
 

COVID 19 VACCINES

Japan Times
BUSINESS / Companies
Jul 17, 2020
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Japan Times
WORLD / FOCUS
Jul 17, 2020
Coronavirus cold war flares up with claims of Russian vaccine hack
The international race for protection from the virus escalated to a new level with allegations that vaccine development has become a target of Russian cyberattacks.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
Japan Times
COMMENTARY / World
Jul 8, 2020
The fight over a coronavirus vaccine will get ugly
Once COVID-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them.
Japan Times
WORLD / Science & Health
Jul 7, 2020
Moderna spars with U.S. scientists over COVID-19 vaccine trials
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc., one of the leading developers, it has been learned.
Japan Times
ASIA PACIFIC / Science & Health
Jul 2, 2020
How China's CanSino Biologics jumped to the front of the coronavirus vaccine race
The firm has boosted its scientific prowess by tying up with the Canadian government's largest research organization, maintaining links despite geopolitical rows.
Japan Times
ASIA PACIFIC
Jun 29, 2020
CanSino's COVID-19 vaccine candidate approved for military use in China
China's military has received the green light to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some efficacy, the company said on Monday.
Japan Times
JAPAN / Science & Health / EXPLAINER
Jun 25, 2020
The race to develop a COVID-19 vaccine, and Japan's place in it
With more than 140 coronavirus measures in development and 13 undergoing trials, hopes are being pinned on one being approved in the near future.
Japan Times
WORLD / Science & Health
Jun 25, 2020
Group finds manufacturing capacity for 4 billion doses of coronavirus vaccines
An influential foundation focused on preparation and response to epidemics that is backing nine potential coronavirus vaccines has identified manufacturers with capacity to produce four billion doses a year, the group's top manufacturing expert said.
Japan Times
ASIA PACIFIC / Science & Health
Jun 20, 2020
Chinese vaccine may not be ready for sale until at least 2021
A coronavirus vaccine candidate China is developing may not be ready for sale until at least 2021, as researchers struggle to move into large-scale human trials in the country because of a lack of new infections, a senior company executive said.
Japan Times
WORLD / ANALYSIS
Jun 19, 2020
We will be living with the coronavirus pandemic well into 2021
The virus is winning. That much is certain more than six months into a shape-shifting pandemic that’s killed 450,000 people worldwide, is gaining ground globally and has disrupted lives from Wuhan to Sao Paulo.
Japan Times
JAPAN / Science & Health
Jun 11, 2020
Japan's AnGes speeds toward 2021 rollout in coronavirus 'vaccine war'
The Osaka-based firm got a headstart in the vaccine development by repurposing its hypertension vaccine, which had already passed various safety hurdles.
Japan Times
ASIA PACIFIC / Science & Health
Jun 11, 2020
China offers in-development vaccines to workers going abroad
China is offering employees of some large state-run companies the option of being inoculated with two coronavirus vaccines currently in development, illustrating how quickly authorities are moving to test the viability of the shots.
Japan Times
WORLD / Science & Health
Jun 2, 2020
Scientists hunt pandemic hot spots in race to test vaccines
The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that could be a problem.
Japan Times
BUSINESS / Markets
May 26, 2020
Japan’s AnGes continues surge as coronavirus vaccine candidate moves closer to human trials
The progress of its drug development has led to wild swings in the stock, with shares falling more than 50 percent in two trading sessions earlier this month.
Japan Times
WORLD / Science & Health
May 23, 2020
U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline
The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters.

Longform

Professional cleaner Hirofumi Sakurai takes a moment to appreciate some photographs in a Gotanda apartment whose occupant died alone. 
The last cleanup: Life and death in a lonely Japan